3Q18 image
Deposition Date 2010-12-16
Release Date 2012-01-25
Last Version Date 2023-11-01
Entry Detail
PDB ID:
3Q18
Keywords:
Title:
Human Glutathione Transferase O2
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.70 Å
R-Value Free:
0.18
R-Value Work:
0.15
R-Value Observed:
0.15
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Glutathione S-transferase omega-2
Gene (Uniprot):GSTO2
Mutations:C80S, C121S, C136S, C140S, C170S, C214S
Chain IDs:A, B
Chain Length:239
Number of Molecules:2
Biological Source:Homo sapiens
Primary Citation
Structural insights into the dehydroascorbate reductase activity of human omega-class glutathione transferases.
J.Mol.Biol. 420 190 203 (2012)
PMID: 22522127 DOI: 10.1016/j.jmb.2012.04.014

Abstact

The reduction of dehydroascorbate (DHA) to ascorbic acid (AA) is a vital cellular function. The omega-class glutathione transferases (GSTs) catalyze several reductive reactions in cellular biochemistry, including DHA reduction. In humans, two isozymes (GSTO1-1 and GSTO2-2) with significant DHA reductase (DHAR) activity are found, sharing 64% sequence identity. While the activity of GSTO2-2 is higher, it is significantly more unstable in vitro. We report the first crystal structures of human GSTO2-2, stabilized through site-directed mutagenesis and determined at 1.9 Å resolution in the presence and absence of glutathione (GSH). The structure of a human GSTO1-1 has been determined at 1.7 Å resolution in complex with the reaction product AA, which unexpectedly binds in the G-site, where the glutamyl moiety of GSH binds. The structure suggests a similar mode of ascorbate binding in GSTO2-2. This is the first time that a non-GSH-based reaction product has been observed in the G-site of any GST. AA stacks against a conserved aromatic residue, F34 (equivalent to Y34 in GSTO2-2). Mutation of Y34 to alanine in GSTO2-2 eliminates DHAR activity. From these structures and other biochemical data, we propose a mechanism of substrate binding and catalysis of DHAR activity.

Legend

Protein

Chemical

Disease

Primary Citation of related structures